Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Owning Sorrento shares is fun. There are now 3 analysts with a $24 price target. It has the largest, most sophisticated Covid portfolio of any pharma. It has 2 potential blockbuster non-opioid pain drugs nearing approval. It has a deep exciting cancer portfolio. And government Covid funding and a big pharma partnership are on the horizon. Everyone should do their own due diligence...have a look. There's a ton of news coming.
1. PSS lawsuit worth $1.2B+
2. BARDA funding, other government funding
3.CYNK-001 NK FDA Phase 1/Phase 2 Trial data with Celularity (Sorrento has 25% stake)
4. STI-4398 (COVIDTRAP) FDA Phase 1 clinical trial data
5. STI-1499 (COVIGUARD)FDA IND approval
6. COVISHIELD(Therapeutic cocktail in partnership with Mt. Sinai Hospital) FDA IND application
7. Preclinical, peer reviewed data publication on STI-1499 and STI-4398 from UTMB, Dr. Slobodan Paessler (2-3 mos).
8. I-Cell COVID 19 Vaccine IND approval
9. Sorrento and SmartPharm gene encoded vaccine IND application
10. Sorrento and MabPharma ACE MAB IND approval
11. Phase 1 trial data of CD 38 for Amyloidosis
12. SP-102 phase 3 results
13. CD38 lymphoma IND
14. RTX arthritis news
15. RTX knee pain news
16. RTX cancer pain news
17. Scilex potential IPO
18. news on several additional cancer programs